PharmProm.Net

Бесплатный вебинар «Автоматизация процессов фармаконадзора на 1С» - https://mailchi.mp/pharmprom/vebinar-antegra-2

Бесплатный семинар «Новое в технологии чистоты...» - https://mailchi.mp/pharmprom/seminar-544381

Бесплатный семинар «Новое в технологии чистоты.
Практический опыт применения технологий фильтрации, водоподготовки и очистки сточных вод на фармацевтическом производстве» - https://mailchi.mp/pharmprom/seminar

Soft Gelatin Capsule - Pharmacy NFT Collection | OpenSea Soft gelatin capsules are manufactured as single piece capsule shell. These capsules are are especially filled with medicinal products and food supplements that are intended for direct oral administration.

Round Tablet - Pharmacy NFT Collection | OpenSea A tablet is a hard, compressed medication in round, oval or square shape. Solid dosage form containing unit dose of one or more medicament.

✅ Pharmaceutical Industry Newsletter from 05/07/22 -

PharmProm NewsLetter All the latest news about Pharmaceutical industry from the PharmProm. Information about Pharmaceutical companies.

Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta to the Eczacıbaşı Group for $135 million.

Gensenta was founded as a lab in 1923 and incorporated as Mustafa Nevzat Pharmaceuticals in 1957. Amgen acquired the company in 2012 and renamed it Gensenta in 2020.

Amgen Sells Its Turkish Manufacturing Arm For $135M Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s Gensenta to the Eczacıbaşı Group for $135 million.

Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which the U.S. government will receive 105 million doses for $3.2 billion, with an option to purchase up to 195 million additional doses.

The agreement provides additional doses for U.S.

Pfizer And BioNTech Announce New $3.2 Billion Agreement To Supply The COVID-19 Vaccine To The US Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which the U.S. government will receive 105

✅ Pharmaceutical Industry Newsletter from 30/06/22 -

PharmProm NewsLetter All the latest news about Pharmaceutical industry from the PharmProm. Information about Pharmaceutical companies.

French drugmaker Sanofi said on Wednesday uninsured diabetes patients in the United States will pay no more than $35 for 30-day supply of insulin, in the wake of heightened public scrutiny over soaring prices of the life-saving drug.

Sanofi said the new price, down from the prior out-of-pocket cost of $99, will be effective from July 1.

U.S.

Sanofi To Cut Out-of-pocket Insulin Costs To $35 For U.S. Patients Sanofi said the new price, down from the prior out-of-pocket cost of $99, will be effective from July 1.

Fujifilm isn’t slowing down on its expansion roll. Just a few months after it bought Shanandoah Biotechnology for an undisclosed sum, the Japanese conglomerate has unveiled a $1.6 billion investment to expand the cell culture manufacturing services of Fujifilm Diosynth Biotechnologies, a CDMO subsidiary.

Fujifilm Plans A $1.6 Billion Expansion At CDMO Facilities In Denmark And Texas The investment will benefit its sites in Hillerød, Denmark, and Texas, and create approximately 450 jobs.

Spero Therapeutics , Inc. shares plunged around 15% after-hours following the company’s announcement, according to which the U.S. Food and Drug Administration (FDA) had completed its review of the New Drug Application (NDA) for tebipenem HBr oral tablets for the treatment of adult patients with complicated urinary tract infection (cUTI)

Spero Therapeutics Plummets 15% As FDA Rejects New Drug Application Spero Therapeutics , Inc. shares plunged around 15% after-hours following the company’s announcement, according to which the U.S. Food and Drug Administration